User Profile
Select your user profile
Events

Pre eclampsia Testing: Where are we now?

Take me to:

Welcome

The ‘Pre-eclampsia testing: where are we now?’ symposium was held on Tuesday 11 October.

During this virtual event we discussed the latest guidance on PIGF-based testing from NICE (DG49 formally DG23) and how this could impact clinical practice. Discussions were chaired by Professor Jenny Myers, Professor of Obstetrics & Maternal Medicine Consultant Obstetrician at Maternal & Fetal Health Research Centre, University of Manchester.

The objective is simple; engage with other clinicians to create partnerships in the pre-eclampsia and pregnancy care community.

NICE DG49 update and what it's really like to use the “Ratio” test - Professor Jenny Myers – Professor of Obstetrics & Maternal Medicine Consultant Obstetrician at Maternal & Fetal Health Research Centre, University of Manchester.

Medtech Funding Mandate and pre-eclampsia - Sarah Tyers – MedTech Funding Mandate policy lead, Innovation Research and Life Sciences, NHS England.

First-trimester screening for pre-eclampsia using PIGF - Professor Ranjit Akolekar – Consultant in Fetal Medicine and Obstetrics at Medway NHS Foundation Trust.

 

Watch the recording of this symposium on demand now.

Watch the webinar recording now

Speakers

Professor Jenny Myers

Professor Jenny Myers - Chair

Professor of Obstetrics & Maternal Medicine Consultant Obstetrician at Maternal & Fetal Health Research Centre, University of Manchester

Jenny Myers is Professor of Obstetrics & Maternal Medicine within the Maternal & Fetal Health Research Centre, University of Manchester and Consultant Obstetrician, St Mary’s Hospital. As an obstetrician, Jenny works on the labour ward of this busy tertiary unit (>9000 deliveries), leads the diabetic, renal and hypertension service and runs two translational research clinics for women with hypertension and diabetes. She currently leads a portfolio of clinical and laboratory science studies which spans vascular and placental biology research, preclinical models, observational cohort studies and intervention trials before, during and after pregnancy. Jenny is also the lead site investigator for several multicenter studies related to hypertension and diabetes in pregnancy. Jenny chairs the North West pre-eclampsia Guideline Group, is the Maternal Medicine representative for the British Maternal & Fetal Medicine Society, is a Consulting Editor for Plos Medicine, President of the RCOG Blair Bell Research Society and has served on several NICE committees.

Sarah Tyers

Sarah Tyers

MedTech Funding Mandate policy lead, Innovation Research and Life Sciences, NHS England

Sarah joined the NHS in 1996 and worked at her local trust for 21 years in various finance roles with a passion for costing, working with services to recognise efficiency and identify opportunities. Following a secondment to the DHSC Reference Cost Collection team she joined NHS Improvement to work with the national Costing Transformation Programme, transitioning to Patient Level Information Costing and Systems (PLICS). Working with the Innovation Research and Life Sciences team to understand how supported technologies could be identified in PLICS led to a desire to work in this field, to make a difference to patients by developing the MedTech Funding Mandate policy ready for its maiden launch in April 2021 and managing its growth since. Sarah is currently studying for a MSc in Health Policy at Imperial College London to support her career in policy development.

 

Professor Ranjit Akolekar

Professor Ranjit Akolekar

Consultant in Fetal Medicine and Obstetrics at Medway NHS Foundation Trust

Rajit is a consultant with 200 peer-reviewed reseach publications and over 18,000 citations. His research interests include prevention of stillbirths with a particular interest in prediction of complications related to placenta and umbilical cord. Ranjit is affilited with the Medway Fetal & Maternal Medicine Center as well as the Institute of Medical Sciences, Canterbury Christ Church University.